ATTRACT: Contacts

Investigator Contacts for recruiting institutions 

Project: UK Issues related to production of therapeutic T cells
Dave Gilham,
University of Manchester

Project: Preclinical models for adoptive T cell therapy using engineered tumor specific T cells.
Zelig Eshhar
Weizmann Institute, Israel

Project: Novel tumour antigens as targets for receptio r-engineered T cells
Reno Debets,
Erasmus MC, Rotterdam, NL

Project: Optimising transduction and function of T cells.
Claudio Bordignon,
Molmed, Milan, IT

Project: Isolation and valildation of new TCRs for gene therapy of prostate cancer and melanoma
Ton Schumacher,
NKI, Amsterdam, NL

Project: Improving the safety of gene-modified T cells
Thomas Blankenstein,
MDC, Berlin, Germany  

Project: Homing and persistence of gene-modified T cells
Naomi Taylor,
CNRS, Montpellier, France

Project: Clinical Trials of Cell Therapy
Fiona Thistlethwaite ,
The Christie, Manchester UK

Project: Defining the impact of adoptive T cell transplant on immune competence
Anna Mondino ,
San Raffaele, Milan, Italy

Project: Optimization of adoptive T cell therapy by chemokine receptor-directed homing to tumor cells.
Paola Allavena,
Humanitas, Milan, Italy

Investigators where fellows already recruited

Project: Gene modified T cell subsets for adoptive transfer
Hinrich Abken,
University of Cologne, Germany  

Project: Isolation and validation of new TCRs for gene therapy of haematological malignancies
Hans Stauss,
UCL, London, UK  

Project: Isolation, expansion and characterisation o f T cells for adoptive immunotherapy
Alexander Scheffold,
Miltenyi, Germany

Institutions not hosting fellowships

Adrian Abbotts, GE Healthcare, UK
Janos Szollosi, University of Debrecen, Hungary
Richard Dennett, Eden Biodesign, UK

UK Coordinator

UK Coordinator: Robert Hawkins
University of Manchester

Page last modified on 11 may 10 12:31 by Karen Rumsey